Douglas Johnson
MD, MSCI
Associate Professor of Medicine
👥Biography 个人简介
Douglas Johnson at Vanderbilt University is a national leader in immune-related adverse events with particular expertise in cardiovascular toxicity from checkpoint inhibitors. He has characterized the clinical presentation, pathophysiology, and management of immune-mediated myocarditis, one of the most dangerous irAEs. His multidisciplinary work has informed international guidelines for irAE cardiotoxicity management.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Douglas Johnson 的研究动态
Follow Douglas Johnson's research updates
留下邮箱，当我们发布与 Douglas Johnson（Vanderbilt University Medical Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment